Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suprainguinal Fascia Iliaca Block for Pain Control in Hip Replacement
NCT04690647Completed
- Start
- Sep 2018
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine in postoperative pain (3 arms). Primary endpoints: Opioid consumption at 48 hours, Opioid related adverse effects at 48 hours and 1 more. Started Sep 2018; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04690647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04690647.